These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28181410)
1. Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation. Xue R; Zeng J; Chen Y; Chen C; Tan W; Zhao J; Dong B; Sun Y; Dong Y; Liu C J Cell Mol Med; 2017 Jun; 21(6):1193-1205. PubMed ID: 28181410 [TBL] [Abstract][Full Text] [Related]
2. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Li Y; Chen C; Yao F; Su Q; Liu D; Xue R; Dai G; Fang R; Zeng J; Chen Y; Huang H; Ma Y; Li W; Zhang L; Liu C; Dong Y Arch Biochem Biophys; 2014 Sep; 558():79-86. PubMed ID: 25009141 [TBL] [Abstract][Full Text] [Related]
3. DJ-1 activates autophagy in the repression of cardiac hypertrophy. Xue R; Jiang J; Dong B; Tan W; Sun Y; Zhao J; Chen Y; Dong Y; Liu C Arch Biochem Biophys; 2017 Nov; 633():124-132. PubMed ID: 28941803 [TBL] [Abstract][Full Text] [Related]
4. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2. Dong B; Xue R; Sun Y; Dong Y; Liu C Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371 [TBL] [Abstract][Full Text] [Related]
5. REDD1 attenuates cardiac hypertrophy via enhancing autophagy. Liu C; Xue R; Wu D; Wu L; Chen C; Tan W; Chen Y; Dong Y Biochem Biophys Res Commun; 2014 Nov; 454(1):215-20. PubMed ID: 25450383 [TBL] [Abstract][Full Text] [Related]
6. Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity. Li R; Huang Y; Semple I; Kim M; Zhang Z; Lee JH Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H39-H48. PubMed ID: 31026186 [TBL] [Abstract][Full Text] [Related]
7. Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy. Wang ZP; Shen D; Che Y; Jin YG; Wang SS; Wu QQ; Zhou H; Meng YY; Yuan Y Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31746323 [TBL] [Abstract][Full Text] [Related]
8. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy. Gao M; Hu F; Hu M; Hu Y; Shi H; Zhao GJ; Jian C; Ji YX; Zhang XJ; She ZG; Li H; Zhu L Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32964914 [TBL] [Abstract][Full Text] [Related]
9. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway. Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA302-367-PI3K-PTEN-AKT-mTORC1 pathway promotes the development of cardiac hypertrophy through controlling autophagy. Jin L; Zhou Y; Han L; Piao J In Vitro Cell Dev Biol Anim; 2020 Feb; 56(2):112-119. PubMed ID: 31845077 [TBL] [Abstract][Full Text] [Related]
12. Ghrelin inhibited pressure overload-induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway. Lu W; Cai H; Chen Y; Liao X; Zhang L; Ma T; Sun H; Qi Y Peptides; 2021 Feb; 136():170446. PubMed ID: 33197510 [TBL] [Abstract][Full Text] [Related]
13. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte. Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056 [TBL] [Abstract][Full Text] [Related]
14. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. Kang S; Chemaly ER; Hajjar RJ; Lebeche D J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152 [TBL] [Abstract][Full Text] [Related]
15. Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer. Wei JL; Fang M; Fu ZX; Zhang SR; Guo JB; Wang R; Lv ZB; Xiong YF Oncotarget; 2017 Jul; 8(30):49318-49328. PubMed ID: 28525387 [TBL] [Abstract][Full Text] [Related]
16. The RING-domain E3 ubiquitin ligase RNF146 promotes cardiac hypertrophy by suppressing the LKB1/AMPK signaling pathway. Sheng Z; Xu J; Li F; Yuan Y; Peng X; Chen S; Zhou R; Huang W Exp Cell Res; 2022 Jan; 410(1):112954. PubMed ID: 34856161 [TBL] [Abstract][Full Text] [Related]
17. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload. Zhou N; Ma B; Stoll S; Hays TT; Qiu H Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247 [TBL] [Abstract][Full Text] [Related]
18. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670 [TBL] [Abstract][Full Text] [Related]
19. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy. Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939 [TBL] [Abstract][Full Text] [Related]
20. Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway. Kim HJ; Joe Y; Kim SK; Park SU; Park J; Chen Y; Kim J; Ryu J; Cho GJ; Surh YJ; Ryter SW; Kim UH; Chung HT Free Radic Biol Med; 2017 Sep; 110():81-91. PubMed ID: 28578014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]